Insider trading

Period: 120 months Stock: EXEL Plan: Not stated × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

312 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

312 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

312 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

312 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
312 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
312 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

312 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
10 Mar 2023
Sold, plan not stated
$254.13K 15,300 at 16.61
4.6%
1 Mar 2023
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold, plan not stated
$1.33M 77,860 at 17.13
12.9%
28 Feb 2023
Aftab Dana CSO/EVP Disc & Trans Research
Sold, plan not stated
$1.44M 82,490 at 17.50
19.0%
27 Feb 2023
Aftab Dana CSO/EVP Disc & Trans Research
Sold, plan not stated
$175.00 10 at 17.50
0.0%
21 Feb 2023
Garber Alan M Director
Sold, plan not stated
$699.60K 40,000 at 17.49
56.0%
Sold half or more
9 Feb 2023
FELDBAUM CARL B Director
Sold, plan not stated
$711.20K 40,000 at 17.78
68.1%
Sold half or more
6 Feb 2023
Haley Patrick J. EVP, Commercial
Sold, plan not stated
$434.25K 25,000 at 17.37
8.9%
15 Dec 2022
Lamb Peter EVP, Scientific Strategy & CSO
Sold, plan not stated
$317.60K 20,000 at 15.88
4.6%
29 Nov 2022
POSTE GEORGE Director
Sold, plan not stated
$667.20K 40,000 at 16.68
17.2%
12 Sep 2022
Haley Patrick J. EVP, Commercial
Sold, plan not stated
$717.60K 40,000 at 17.94
13.3%
27 May 2022
Haley Patrick J. EVP, Commercial
Sold, plan not stated
$342.57K 18,812 at 18.21
7.3%
16 May 2022
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold, plan not stated
$361.26K 18,000 at 20.07
3.0%
12 May 2022
WILLSEY LANCE Director
Sold, plan not stated
$786.00K 40,000 at 19.65
8.6%
4 Apr 2022
Sold, plan not stated
$154.01K 6,696 at 23.00
2.4%
1 Apr 2022
Haley Patrick J. EVP, Commercial
Sold, plan not stated
$230.00K 10,000 at 23.00
3.6%
31 Mar 2022
Haley Patrick J. EVP, Commercial
Sold, plan not stated
$224.30K 10,000 at 22.43
3.6%
29 Mar 2022
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold, plan not stated
$292.23K 13,283 at 22.00
2.1%
28 Mar 2022
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold, plan not stated
$103.77K 4,717 at 22.00
0.8%
1 Mar 2022
Garber Alan M Director
Sold, plan not stated
$447.32K 21,301 at 21.00
40.4%
25 Feb 2022
Haley Patrick J. EVP, Commercial
Sold, plan not stated
$610.08K 31,238 at 19.53
13.6%
24 Feb 2022
Hessekiel Jeffrey EVP and General Counsel
Sold, plan not stated
$360.00K 18,000 at 20.00
3.1%
22 Feb 2022
Sold, plan not stated
$1.65M 84,515 at 19.56
6.5%
22 Feb 2022
FELDBAUM CARL B Director
Sold, plan not stated
$389.80K 20,000 at 19.49
70.1%
Sold half or more
3 Feb 2022
Haley Patrick J. EVP, Commercial
Sold, plan not stated
$1.07M 60,000 at 17.91
19.7%
15 Dec 2021
Lamb Peter EVP, Scientific Strategy & CSO
Sold, plan not stated
$828.40K 47,500 at 17.44
11.6%
24 Nov 2021
Haley Patrick J. EVP, Commercial
Sold, plan not stated
$297.32K 17,236 at 17.25
6.8%
19 Nov 2021
FELDBAUM CARL B Director
Sold, plan not stated
$352.40K 20,000 at 17.62
70.1%
Sold half or more
15 Nov 2021
Lamb Peter EVP, Scientific Strategy & CSO
Sold, plan not stated
$859.28K 47,500 at 18.09
10.4%
1 Nov 2021
Hessekiel Jeffrey EVP and General Counsel
Sold, plan not stated
$112.73K 5,117 at 22.03
0.8%
15 Oct 2021
Lamb Peter EVP, Scientific Strategy & CSO
Sold, plan not stated
$1.04M 47,500 at 21.92
10.4%
15 Oct 2021
Hessekiel Jeffrey EVP and General Counsel
Sold, plan not stated
$283.68K 12,883 at 22.02
2.0%
16 Sep 2021
Haley Patrick J. EVP, Commercial
Sold, plan not stated
$509.00K 25,000 at 20.36
8.2%
15 Sep 2021
Lamb Peter EVP, Scientific Strategy & CSO
Sold, plan not stated
$971.85K 47,500 at 20.46
10.9%
16 Aug 2021
Lamb Peter EVP, Scientific Strategy & CSO
Sold, plan not stated
$1.01M 55,000 at 18.44
12.4%
15 Jul 2021
Lamb Peter EVP, Scientific Strategy & CSO
Sold, plan not stated
$1.05M 60,000 at 17.47
13.3%
17 Jun 2021
Lamb Peter EVP, Scientific Strategy & CSO
Sold, plan not stated
$1.33M 60,000 at 22.18
13.3%
18 May 2021
Haley Patrick J. EVP, Commercial
Sold, plan not stated
$360.88K 14,593 at 24.73
4.9%
17 May 2021
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold, plan not stated
$457.02K 18,000 at 25.39
2.9%
14 May 2021
POSTE GEORGE Director
Sold, plan not stated
$1.02M 40,802 at 24.97
20.6%
14 May 2021
Sold, plan not stated
$1.00M 40,000 at 25.04
37.7%
13 May 2021
Schwab Gisela Pres, Prod Dev & Med Aff & CMO
Sold, plan not stated
$2.54M 100,000 at 25.38
14.0%
11 May 2021
Sold, plan not stated 3×
$518.79K 20,770 at 24.98
1.7%
11 May 2021
Freire Maria C Director
Sold, plan not stated
$206.96K 8,275 at 25.01
20.6%
26 Apr 2021
Schwab Gisela Pres, Prod Dev & Med Aff & CMO
Sold, plan not stated
$1.25M 50,000 at 25.00
7.5%
26 Apr 2021
Hessekiel Jeffrey EVP and General Counsel
Sold, plan not stated
$450.54K 18,000 at 25.03
2.8%
26 Apr 2021
Haley Patrick J. EVP, Commercial
Sold, plan not stated
$191.85K 7,665 at 25.03
2.5%
1 Apr 2021
Lamb Peter EVP, Scientific Strategy & CSO
Sold, plan not stated
$1.38M 60,000 at 22.96
13.3%
1 Apr 2021
Schwab Gisela Pres, Prod Dev & Med Aff & CMO
Sold, plan not stated
$1.15M 50,000 at 23.00
7.5%
29 Mar 2021
Sold, plan not stated
$140.82K 6,220 at 22.64
2.6%
15 Mar 2021
Garber Alan M Director
Sold, plan not stated
$944.00K 40,000 at 23.60
75.9%
Sold half or more
Showing 1–50 of 312. Page 1 of 7 Older →